Barclays Keeps Overweight Rating on FMC Corporation (FMC), Adjusts EPS Forecast After Earnings Surprise

FMC Corporation (NYSE:FMC) ranks among the best mid-cap materials stocks to buy now. On August 13, Barclays reiterated its Overweight rating on FMC Corporation (NYSE:FMC) with a price target of $48, down from $49. The firm’s forecast for FMC’s fiscal year 2025 revenues remains essentially unchanged, estimating flat sales year over year (down 1%), or around $4.2 billion.

Barclays stated that FMC’s second-quarter performance crossed expectations by almost 20%, leading it to modestly increase its adjusted earnings per share projection to $3.45.

The investment bank is keeping an eye on FMC’s new go-to-market strategy, credit, and inventory levels as the company reports its second-half earnings.

Founded in 1883 as an insecticide factory, FMC Corporation (NYSE:FMC) is an American chemical manufacturing company that has since branched out into other industries, including lithium.

While we acknowledge the potential of FMC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.